APLMW
Apollomics, Inc. NASDAQ$0.02
Mkt Cap $236.5M
52w Low $0.02
1.0% of range
52w High $0.03
50d MA $0.03
200d MA $0.03
P/E (TTM)
0.0x
EV/EBITDA
0.0x
P/B
—
Debt/Equity
-0.2x
ROE
—
P/FCF
0.0x
RSI (14)
—
ATR (14)
—
Beta
2.42
50d MA
$0.03
200d MA
$0.03
Avg Volume
86.9K
About
Apollomics, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of oncology therapies to address unmet medical needs. The company was founded by Liang Yu Guo and Sanjeev Redkar in 2015 and is headquartered in Foster City, CA.
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 28, 2024 | AMC | — | -24.00 | — | 0.03 | -13.0% | -13.0% | -13.0% | -56.5% | -46.2% | -40.8% | — |
| Sep 28, 2023 | AMC | — | -255.00 | — | 0.04 | +0.0% | +0.0% | +0.0% | -2.4% | -2.4% | +22.0% | — |
| Dec 31, 2022 | AMC | — | -2.77 | — | — | — | — | — | — | — | — | — |
| Jun 30, 2022 | AMC | — | -0.04 | — | — | — | — | — | — | — | — | — |
| Dec 31, 2021 | AMC | — | -0.01 | — | — | — | — | — | — | — | — | — |
| Jun 30, 2021 | AMC | — | -1.09 | — | — | — | — | — | — | — | — | — |
| Dec 31, 2020 | AMC | — | -0.09 | — | — | — | — | — | — | — | — | — |
| Jun 30, 2020 | AMC | — | -0.50 | — | — | — | — | — | — | — | — | — |
| Dec 31, 2019 | AMC | — | -0.02 | — | — | — | — | — | — | — | — | — |
| Jun 30, 2019 | AMC | — | -0.13 | — | — | — | — | — | — | — | — | — |
Data updated apr 28, 2026 1:39am
· Source: massive.com